Cento, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 522
EU - Europa 106
AF - Africa 59
AS - Asia 1
Totale 688
Nazione #
US - Stati Uniti d'America 513
NG - Nigeria 59
FR - Francia 35
NL - Olanda 25
BE - Belgio 13
GB - Regno Unito 11
FI - Finlandia 9
DE - Germania 8
PA - Panama 7
IT - Italia 3
CA - Canada 2
GR - Grecia 1
IL - Israele 1
PT - Portogallo 1
Totale 688
Città #
Chandler 325
Lawrence 72
Princeton 72
Benin City 59
Paris 35
Amsterdam 25
Brussels 13
Wilmington 13
London 11
Helsinki 9
Ann Arbor 7
Hanover 4
Leawood 3
San Mateo 3
Monmouth Junction 2
Trieste 2
Woodbridge 2
Andover 1
Athens 1
Boardman 1
Eden Prairie 1
Fairfield 1
Frankfurt am Main 1
Lisbon 1
Milan 1
Potomac 1
Seattle 1
Toronto 1
Totale 668
Nome #
Real life experiences in HCV management in 2018 44
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 20
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 17
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 16
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs 14
Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon 14
Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon 14
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients 13
Sex differences in electrolyte imbalances caused by SARS-CoV-2: A cross-sectional study 12
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 12
Back to the future (of common respiratory viruses) 12
Human papillomaviruses 53 and 66: clinical aspects and genetic analysis 12
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy 12
A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy 12
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals 12
Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology 12
Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning 12
Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users 11
The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures 11
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district 11
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 11
Prolongation of incubation time improves clinical diagnosis of Mycobacterium xenopi infection and allows susceptibility testing of mycobacterial strains against multiple antibiotics 11
Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions 11
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 11
Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR? 11
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 10
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing 10
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 10
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy 10
Nasopharyngeal SARS-CoV-2 Load at Hospital Admission as a Predictor of Mortality 10
Biotech innovations in the prevention of respiratory infectious diseases 10
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 10
The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C 9
Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirin 9
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 9
The use of human immunodeficiency virus resistance tests in clinical practice 9
Detecting Hepatitis B Viral Amino Acid Sequence Mutations in Occult Hepatitis B Infections via Bayesian Partition Model 9
Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B inhibitors 9
Resistance to direct-acting antiviral agents: clinical utility and significance 9
Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents 9
HCV very late relapse following an atypical viral kinetics in a HIV patient treated for hepatitis C with direct-acting antivirals 9
Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice-A Refined Approach in the COVID-19 Era 9
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 9
Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients 8
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 8
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018 8
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 8
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients 8
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing 8
May some HCV genotype 1 patients still benefit from dual therapy? The role of very early HCV kinetics 8
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C 8
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development 7
In vivo acquisition and risk of inter-species spread of bla KPC-3-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract 7
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 7
Nucleotide polymorphisms in the 5'-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype 7
Rapid Detection and Quantification of Mycobacterium tuberculosis DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study 7
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study 7
Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine 7
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians 7
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon 7
Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe-short- And long-term Immune reSponSe evAluatioN in health Care workErs 6
Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution 5
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 5
Short article: Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience 4
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 4
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy 4
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 4
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 4
Two-drug regimens with dolutegravir plus rilpivirine or lamivudine in HIV-1 treatment-naïve, virologically-suppressed patients: Latest evidence from the literature on their efficacy and safety 3
Viral Respiratory Infections: New Tools for a Rapid Diagnosis 3
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 3
Viral resistance in HCV infection 3
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 1
Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population 1
Totale 694
Categoria #
all - tutte 5260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5260

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0000 07 62 5210
2021/2022104 0103 10 12 64779
2022/2023567 1491597120 79103 40 0000
Totale 694